Cargando…

Roles of C-reactive protein polymorphisms and life event changes on cognitive function in bipolar patients receiving valproate

INTRODUCTION: Patients with bipolar disorder (BD) exhibit an inflamed condition that is associated with metabolic disturbance and cognitive impairment. Whether inflammation, represented by C-reactive protein (CRP), is causally associated with BD and influences treatment outcome has not been establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po See, Tang, Li-Yi, Chang, Hui Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Inflammatory Mediators in COVID-19 and Other Diseases - Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984865/ https://www.ncbi.nlm.nih.gov/pubmed/35377256 http://dx.doi.org/10.1177/03946320221084835

Ejemplares similares

Immune system changes during COVID-19 recovery play key role in determining disease severity
por: Fathi, Farshid, et al.
Publicado: (2020)

SARS-CoV-2 (COVID-19) and audio-vestibular disorders
por: Fancello, Virginia, et al.
Publicado: (2021)

C1q/TNF-related protein-1: Potential biomarker for early diagnosis of autism spectrum disorder
por: Raeisy, Hamed, et al.
Publicado: (2022)

Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq
por: Hwaiz, Rundk Ahmad, et al.
Publicado: (2022)

COVID-19 and erythrocrine function: The roller coaster and danger
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022)

Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
por: Fathalla, Lamiaa A, et al.
Publicado: (2022)

Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19
por: Zamani, Batool, et al.
Publicado: (2022)

Mitochondrial DNA Copy Number Is Associated With Treatment Response and Cognitive Function in Euthymic Bipolar Patients Receiving Valproate
por: Chang, Cheng-Chen, et al.
Publicado: (2022)

Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience
por: Hoque, Sami, et al.
Publicado: (2020)

SG-APSIC1113: Descriptive study on COVID-19 exposures in Singapore General Hospital
por: Shawn See, Wee Jin
Publicado: (2023)

Improvement of inflammatory dermatoses severity and quality of life in patients treated with a betamethasone valerate plaster (LIBERE study)
por: Maccari, Francois
Publicado: (2016)

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2011)

Effectiveness of disease-specific cognitive–behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD)
por: van den Brink, Gertrude, et al.
Publicado: (2016)

Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis
por: van der Post, Sjoerd, et al.
Publicado: (2019)

The role of C-reactive protein as a prognostic marker in COVID-19
por: Stringer, Dominic, et al.
Publicado: (2021)

COVID-19 and Ventilator-Associated Event Discordance
por: Cawcutt, Kelly, et al.
Publicado: (2021)

Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series
por: Kapoor, Rajan, et al.
Publicado: (2021)

Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2021)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

“Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis”
por: Sanjay, Srinivasan, et al.
Publicado: (2021)

Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK
por: Cummings, JR Fraser, et al.
Publicado: (2021)

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
por: Gisondi, Paolo, et al.
Publicado: (2021)

The effects of COVID-19 pandemic countermeasures on patients receiving botulinum toxin therapy and on their caregivers: a study from an Italian cohort
por: Tarantino, Domiziano, et al.
Publicado: (2021)

Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia
por: Kaufman, Jessica, et al.
Publicado: (2022)

Life in lockdown: experiences of patients with IBD during COVID-19
por: Harris, Richard James, et al.
Publicado: (2020)

Adverse Events Following COVISHIELD Vaccination Among Adult Population in Bangladesh
por: Khalil, Md. Musab, et al.
Publicado: (2021)

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
por: Cornillie, Freddy, et al.
Publicado: (2014)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19
por: Kundura, Lucy, et al.
Publicado: (2022)

A pilot feasibility trial of cognitive–behavioural therapy for insomnia in people with inflammatory bowel disease
por: Salwen-Deremer, Jessica K, et al.
Publicado: (2021)

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands
por: de Bock, Ellen, et al.
Publicado: (2021)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
por: Noh, Yunha, et al.
Publicado: (2023)

Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations
por: Iodice, Francesco, et al.
Publicado: (2021)

Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report
por: Patrocínio de Jesus, Rita, et al.
Publicado: (2020)

Physical and mental health characteristics related to trust in and intention to receive COVID-19 vaccination: results from a Korean community-based longitudinal study
por: Jeon, Ye Jin, et al.
Publicado: (2022)

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
por: Villalba, Gonzalo Cabezón, et al.
Publicado: (2021)

Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in 286 Patients
por: Mani, Avinash, et al.
Publicado: (2022)

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022)

Evaluation of cognitive functions in adult individuals with COVID-19
por: Akıncı, Büşra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iv989smrv1vno87ir11ab5ct7v